{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:06:13Z","timestamp":1793711173394,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00415-023-12070-w","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:55:26Z","timestamp":1699073726000},"page":"1331-1341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series"],"prefix":"10.1007","volume":"271","author":[{"given":"Alessia","family":"Pugliese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Della Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"de Paula Estephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmar","family":"Zanoteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"T\u00f6pf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Polavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"12070_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","volume":"6","author":"M Tartaglia","year":"2005","unstructured":"Tartaglia M, Gelb BD (2005) Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genom Hum Genet 6:45\u201368","journal-title":"Annu Rev Genom Hum Genet"},{"key":"12070_CR2","first-page":"968","volume":"67","author":"J Opitz","year":"1965","unstructured":"Opitz J, Summitt R, Sarto G (1965) Noonan\u2019s syndrome in girls: a genocopy of the Ullrich-Turner syndrome. J Pediatr 67:968","journal-title":"J Pediatr"},{"key":"12070_CR3","first-page":"468","volume":"63","author":"J Noonan","year":"1963","unstructured":"Noonan J, Ehmke D (1963) Associated noncardiac malformations in children with congenital heart disease. J Pediatr 63:468\u2013470","journal-title":"J Pediatr"},{"issue":"3","key":"12070_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/ajmg.1320210312","volume":"21","author":"HM Mendez","year":"1985","unstructured":"Mendez HM, Opitz JM (1985) Noonan syndrome: a review. Am J Med Genet 21(3):493-506. https:\/\/doi.org\/10.1002\/ajmg.1320210312","journal-title":"Am J Med Genet"},{"key":"12070_CR5","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1111\/j.1440-1754.2010.01970.x","volume":"50","author":"AM Turner","year":"2014","unstructured":"Turner AM (2014) Noonan syndrome. J Paediatr Child Health 50:E14\u2013E20","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"12070_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0735-1097(93)90436-5","volume":"22","author":"M Burch","year":"1993","unstructured":"Burch M, Sharland M, Shinebourne E, et al (1993) Cardiologic abnormalities in noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 Patients. J Am Coll Cardiol 22(4):1189-1192. https:\/\/doi.org\/10.1016\/0735-1097(93)90436-5","journal-title":"J Am Coll Cardiol"},{"key":"12070_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ajmg.c.31765","volume":"184","author":"L Linglart","year":"2020","unstructured":"Linglart L, Gelb BD (2020) Congenital heart defects in Noonan syndrome: diagnosis, management, and treatment. Am J Med Genet C Semin Med Genet 184:73\u201380. https:\/\/doi.org\/10.1002\/ajmg.c.31765","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"12070_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","volume":"126","author":"AA Romano","year":"2010","unstructured":"Romano AA, Allanson JE, Dahlgren J et al (2010) Noonan syndrome: Clinical features, diagnosis, and management guidelines. Pediatrics 126:746\u2013759","journal-title":"Pediatrics"},{"key":"12070_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","volume":"25","author":"M Tartaglia","year":"2011","unstructured":"Tartaglia M, Gelb BD, Zenker M (2011) Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 25:161\u2013179","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"12070_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-3-13","volume":"3","author":"A Sarkozy","year":"2008","unstructured":"Sarkozy A, Digilio MC, Dallapiccola B (2008) Leopard syndrome. Orphanet J Rare Dis 3:13","journal-title":"Orphanet J Rare Dis"},{"key":"12070_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R et al (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465\u2013468. https:\/\/doi.org\/10.1038\/ng772","journal-title":"Nat Genet"},{"key":"12070_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ejhg.2010.171","volume":"19","author":"T Kleefstra","year":"2011","unstructured":"Kleefstra T, Wortmann SB, Rodenburg RJT et al (2011) Mitochondrial dysfunction and organic aciduria in five patients carrying mutations in the Ras-MAPK pathway. Eur J Hum Genet 19:138\u2013144. https:\/\/doi.org\/10.1038\/ejhg.2010.171","journal-title":"Eur J Hum Genet"},{"key":"12070_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/mus.23324","volume":"46","author":"DA Stevenson","year":"2012","unstructured":"Stevenson DA, Allen S, Tidyman WE et al (2012) Peripheral muscle weakness in RASopathies. Muscle Nerve 46:394\u2013399. https:\/\/doi.org\/10.1002\/mus.23324","journal-title":"Muscle Nerve"},{"key":"12070_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s004010050566","volume":"92","author":"WP de Boode","year":"1996","unstructured":"de Boode WP, Semmekrot BA, ter Laak HJ et al (1996) Myopathology in patients with a Noonan phenotype. Acta Neuropathol 92:597\u2013602. https:\/\/doi.org\/10.1007\/s004010050566","journal-title":"Acta Neuropathol"},{"key":"12070_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/mus.880120802","volume":"12","author":"J Keesey","year":"1989","unstructured":"Keesey J (1989) AAEE Minimonograph #33: electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 12:613\u2013626. https:\/\/doi.org\/10.1002\/mus.880120802","journal-title":"Muscle Nerve"},{"key":"12070_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24353","author":"S Laurie","year":"2022","unstructured":"Laurie S, Piscia D, Matalonga L et al (2022) The RD-connect genome-phenome analysis platform: accelerating diagnosis, research, and gene discovery for rare diseases. Hum Mutat. https:\/\/doi.org\/10.1002\/humu.24353","journal-title":"Hum Mutat"},{"key":"12070_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"12070_CR18","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jprot.2011.11.016","volume":"75","author":"J Burkhart","year":"2012","unstructured":"Burkhart J, Schumbrutzki C, Wortelkamp S et al (2012) Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J Proteom 75:1454\u20131462","journal-title":"J Proteom"},{"key":"12070_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","volume":"28","author":"BG Neel","year":"2003","unstructured":"Neel BG, Gu H, Pao L (2003) The \u2019Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284\u2013293","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"12070_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0092-8674(95)90498-0","volume":"80","author":"TL Tang","year":"1995","unstructured":"Tang TL, Freeman RM, O\u2019reilly AM et al (1995) The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80(3):473\u2013483. https:\/\/doi.org\/10.1016\/0092-8674(95)90498-0","journal-title":"Cell"},{"issue":"1","key":"12070_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/dbio.1996.0285","volume":"180","author":"LA Perkins","year":"1996","unstructured":"Perkins LA, Johnson MR, Melnick MB, Perrimon N (1996) The nonreceptor protein tyrosine phosphatase corkscrew functions in multiple receptor tyrosine kinase pathways in Drosophila. Dev Biol 180(1):63\u201381. https:\/\/doi.org\/10.1006\/dbio.1996.0285","journal-title":"Dev Biol"},{"issue":"35","key":"12070_CR22","doi-asserted-by":"publisher","first-page":"21353","DOI":"10.1074\/jbc.271.35.21353","volume":"271","author":"JM Arrandale","year":"1996","unstructured":"Arrandale JM, Gore-Willse A, Rocks S et al (1996) Insulin signaling in mice expressing reduced levels of Syp. J Biol Chem 271(35):21353\u201321358. https:\/\/doi.org\/10.1074\/jbc.271.35.21353","journal-title":"J Biol Chem"},{"issue":"9","key":"12070_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1093\/emboj\/16.9.2352","volume":"16","author":"TM Saxton","year":"1997","unstructured":"Saxton TM, Henkemeyer M, Tonks S et al (1997) Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J 16(9):2352\u20132364. https:\/\/doi.org\/10.1093\/emboj\/16.9.2352","journal-title":"EMBO J"},{"key":"12070_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1089\/gte.2006.10.186","volume":"10","author":"DR Bertola","year":"2006","unstructured":"Bertola DR, Pereira AC, Albano LMJ et al (2006) PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype. Genet Test 10:186\u2013191. https:\/\/doi.org\/10.1089\/gte.2006.10.186","journal-title":"Genet Test"},{"key":"12070_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00431-011-1487-5","volume":"171","author":"A Papadopoulou","year":"2012","unstructured":"Papadopoulou A, Issakidis M, Gole E et al (2012) Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment. Eur J Pediatr 171:51\u201358","journal-title":"Eur J Pediatr"},{"key":"12070_CR26","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.1074\/jbc.M112.350231","volume":"287","author":"S Martinelli","year":"2012","unstructured":"Martinelli S, Nardozza AP, Vigne SD et al (2012) Counteracting effects operating on Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP2) function drive selection of the recurrent Y62D and Y63C substitutions in Noonan syndrome. J Biol Chem 287:27066\u201327077. https:\/\/doi.org\/10.1074\/jbc.M112.350231","journal-title":"J Biol Chem"},{"key":"12070_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/ene.15173","volume":"29","author":"EP Estephan","year":"2022","unstructured":"Estephan EP, Zambon AA, Thompson R et al (2022) Congenital myasthenic syndrome: correlation between clinical features and molecular diagnosis. Eur J Neurol 29:833\u2013842. https:\/\/doi.org\/10.1111\/ene.15173","journal-title":"Eur J Neurol"},{"issue":"6","key":"12070_CR28","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia M, Kalidas K, Shaw A et al (2002) PTPN11 mutations in noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70(6):1555-1563. https:\/\/doi.org\/10.1086\/340847","journal-title":"Am J Hum Genet"},{"key":"12070_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.ejhg.5200935","volume":"11","author":"L Musante","year":"2003","unstructured":"Musante L, Kehl HG, Majewski F et al (2003) Spectrum of mutations in PTPN11 and genotype - phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet 11:201\u2013206. https:\/\/doi.org\/10.1038\/sj.ejhg.5200935","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"12070_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/341528","volume":"71","author":"MC Digilio","year":"2002","unstructured":"Digilio MC, Conti E, Sarkozy A et al (2002) Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71(2):389\u2013394. https:\/\/doi.org\/10.1086\/341528","journal-title":"Am J Hum Genet"},{"key":"12070_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-0986-5","author":"JP Athota","year":"2020","unstructured":"Athota JP, Bhat M, Nampoothiri S et al (2020) Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations. BMC Med Genet. https:\/\/doi.org\/10.1186\/s12881-020-0986-5","journal-title":"BMC Med Genet"},{"key":"12070_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12883-015-0310-8","volume":"15","author":"M Spatola","year":"2015","unstructured":"Spatola M, Wider C, Kuntzer T, Croquelois A (2015) PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain. BMC Neurol 15:55. https:\/\/doi.org\/10.1186\/s12883-015-0310-8","journal-title":"BMC Neurol"},{"key":"12070_CR33","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0929-6646(09)60408-3","volume":"108","author":"I-S Lin","year":"2009","unstructured":"Lin I-S, Wang J-N, Chao S-C et al (2009) PTPN11 mutations in LEOPARD syndrome: report of four cases in Taiwan. J Formos Med Assoc 108:803\u2013807. https:\/\/doi.org\/10.1016\/S0929-6646(09)60408-3","journal-title":"J Formos Med Assoc"},{"key":"12070_CR34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/ajmg.a.31991","volume":"143A","author":"K Writzl","year":"2007","unstructured":"Writzl K, Hoovers J, Sistermans EA, Hennekam RCM (2007) LEOPARD syndrome with partly normal skin and sex chromosome mosaicism. Am J Med Genet A 143A:2612\u20132615. https:\/\/doi.org\/10.1002\/ajmg.a.31991","journal-title":"Am J Med Genet A"},{"key":"12070_CR35","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1136\/jmg.2004.021451","volume":"41","author":"B Keren","year":"2004","unstructured":"Keren B, Hadchouel A, Saba S et al (2004) PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet 41:e117\u2013e117. https:\/\/doi.org\/10.1136\/jmg.2004.021451","journal-title":"J Med Genet"},{"key":"12070_CR36","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","volume":"580","author":"N Hanna","year":"2006","unstructured":"Hanna N, Montagner A, Lee WH et al (2006) Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1. FEBS Lett 580:2477\u20132482. https:\/\/doi.org\/10.1016\/j.febslet.2006.03.088","journal-title":"FEBS Lett"},{"key":"12070_CR37","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/hmg\/ddn099","volume":"17","author":"S Martinelli","year":"2008","unstructured":"Martinelli S, Torreri P, Tinti M et al (2008) Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes. Hum Mol Genet 17:2018\u20132029. https:\/\/doi.org\/10.1093\/hmg\/ddn099","journal-title":"Hum Mol Genet"},{"key":"12070_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/hmg\/ddn336","volume":"18","author":"K Oishi","year":"2009","unstructured":"Oishi K, Zhang H, Gault WJ et al (2009) Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development. Hum Mol Genet 18:193\u2013201. https:\/\/doi.org\/10.1093\/hmg\/ddn336","journal-title":"Hum Mol Genet"},{"key":"12070_CR39","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1021\/bi5002695","volume":"53","author":"Z-H Yu","year":"2014","unstructured":"Yu Z-H, Zhang R-Y, Walls CD et al (2014) Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations. Biochemistry 53:4136\u20134151. https:\/\/doi.org\/10.1021\/bi5002695","journal-title":"Biochemistry"},{"key":"12070_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajmg.c.30296","volume":"157","author":"DA Stevenson","year":"2011","unstructured":"Stevenson DA, Yang FC (2011) The musculoskeletal phenotype of the RASopathies. Am J Med Genet C Semin Med Genet 157:90\u2013103. https:\/\/doi.org\/10.1002\/ajmg.c.30296","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"12070_CR41","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/hmg\/ddr149","volume":"20","author":"N Kossler","year":"2011","unstructured":"Kossler N, Stricker S, R\u00f6delsperger C et al (2011) Neurofibromin (Nf1) is required for skeletal muscle development. Hum Mol Genet 20:2697\u20132709. https:\/\/doi.org\/10.1093\/hmg\/ddr149","journal-title":"Hum Mol Genet"},{"key":"12070_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1515\/JPM.2005.034","volume":"33","author":"S Stassou","year":"2005","unstructured":"Stassou S, Nadroo A, Schubert R et al (2005) A new syndrome of myopathy with muscle spindle excess. J Perinat Med 33:179\u2013182","journal-title":"J Perinat Med"},{"key":"12070_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajmg.c.30298","volume":"157","author":"WE Tidyman","year":"2011","unstructured":"Tidyman WE, Lee HS, Rauen KA (2011) Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras\/MAPK activation on myogenesis. Am J Med Genet C Semin Med Genet 157:104\u2013114. https:\/\/doi.org\/10.1002\/ajmg.c.30298","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"12070_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2350\/09-06-0664-CR.1","volume":"14","author":"M Sinico","year":"2011","unstructured":"Sinico M, Bassez G, Touboul C et al (2011) Excess of neuromuscular spindles in a fetus with Costello syndrome: a clinicopathological report. Pediatr Dev Pathol 14:218\u2013223. https:\/\/doi.org\/10.2350\/09-06-0664-CR.1","journal-title":"Pediatr Dev Pathol"},{"key":"12070_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbadis.2009.10.005","volume":"1802","author":"I Lee","year":"2010","unstructured":"Lee I, Pecinova A, Pecina P et al (2010) A suggested role for mitochondria in Noonan syndrome. Biochim Biophys Acta Mol Basis Dis 1802:275\u2013283. https:\/\/doi.org\/10.1016\/j.bbadis.2009.10.005","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"12070_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2350-15-44","volume":"15","author":"C Santoro","year":"2014","unstructured":"Santoro C, Pacileo G, Limongelli G et al (2014) LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies. BMC Med Genet 15:44. https:\/\/doi.org\/10.1186\/1471-2350-15-44","journal-title":"BMC Med Genet"},{"key":"12070_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2202-9-70","volume":"9","author":"YK Qian","year":"2008","unstructured":"Qian YK, Chan AW, Madhavan R, Peng HB (2008) The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters. BMC Neurosci 9:70. https:\/\/doi.org\/10.1186\/1471-2202-9-70","journal-title":"BMC Neurosci"},{"key":"12070_CR48","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000645","volume":"7","author":"S Huda","year":"2020","unstructured":"Huda S, Cao M, De Rosa A et al (2020) SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody. Neurol Neuroimmunol Neuroinflamm 7:e645. https:\/\/doi.org\/10.1212\/NXI.0000000000000645","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"12070_CR49","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/hmg\/ddy062","volume":"27","author":"G McMacken","year":"2018","unstructured":"McMacken G, Cox D, Roos A et al (2018) The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes. Hum Mol Genet 27:1556\u20131564. https:\/\/doi.org\/10.1093\/hmg\/ddy062","journal-title":"Hum Mol Genet"},{"key":"12070_CR50","doi-asserted-by":"publisher","first-page":"1700073","DOI":"10.1002\/prca.201700073","volume":"12","author":"A Roos","year":"2018","unstructured":"Roos A, Thompson R, Horvath R et al (2018) Intersection of proteomics and genomics to \u201csolve the unsolved\u201d in Rare disorders such as neurodegenerative and neuromuscular diseases. Proteom Clin Appl 12:1700073. https:\/\/doi.org\/10.1002\/prca.201700073","journal-title":"Proteom Clin Appl"},{"key":"12070_CR51","doi-asserted-by":"publisher","first-page":"68493","DOI":"10.18632\/oncotarget.19663","volume":"8","author":"L Kollipara","year":"2017","unstructured":"Kollipara L, Buchkremer S, Coraspe JAG et al (2017) In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sj\u00f6gren syndrome. Oncotarget 8:68493\u201368516. https:\/\/doi.org\/10.18632\/oncotarget.19663","journal-title":"Oncotarget"},{"key":"12070_CR52","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/humu.24338","volume":"43","author":"A Gangfu\u00df","year":"2022","unstructured":"Gangfu\u00df A, Hentschel A, Rademacher N et al (2022) Identification of a novel homozygous synthesis of cytochrome c oxidase 2 variant in siblings with early-onset axonal Charcot-Marie-Tooth disease. Hum Mutat 43:477\u2013486. https:\/\/doi.org\/10.1002\/humu.24338","journal-title":"Hum Mutat"},{"key":"12070_CR53","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1523\/JNEUROSCI.3158-16.2017","volume":"37","author":"MR Van Horn","year":"2017","unstructured":"Van Horn MR, Strasser A, Miraucourt LS et al (2017) The gliotransmitter d-serine promotes synapse maturation and axonal stabilization in vivo. J Neurosci 37:6277\u20136288. https:\/\/doi.org\/10.1523\/JNEUROSCI.3158-16.2017","journal-title":"J Neurosci"},{"key":"12070_CR54","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/brain\/awab133","volume":"144","author":"D Hathazi","year":"2021","unstructured":"Hathazi D, Cox D, D\u2019Amico A et al (2021) INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH. Brain 144:2427\u20132442. https:\/\/doi.org\/10.1093\/brain\/awab133","journal-title":"Brain"},{"key":"12070_CR55","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.3390\/jcm10194575","volume":"10","author":"M Dulewicz","year":"2021","unstructured":"Dulewicz M, Kulczy\u0144ska-Przybik A, S\u0142owik A et al (2021) Neurogranin and neuronal pentraxin receptor as synaptic dysfunction biomarkers in Alzheimer\u2019s disease. J Clin Med 10:4575. https:\/\/doi.org\/10.3390\/jcm10194575","journal-title":"J Clin Med"},{"key":"12070_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jnen\/59.7.592","volume":"59","author":"V Askanas","year":"2000","unstructured":"Askanas V, Engel WK, Alvarez RB et al (2000) Novel Immunolocalization of \u03b1-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions. J Neuropathol Exp Neurol 59:592\u2013598. https:\/\/doi.org\/10.1093\/jnen\/59.7.592","journal-title":"J Neuropathol Exp Neurol"},{"key":"12070_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac324","author":"M Stam","year":"2022","unstructured":"Stam M, Wijngaarde CA, Bartels B et al (2022) Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2\u20134. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcac324","journal-title":"Brain Commun"},{"key":"12070_CR58","doi-asserted-by":"publisher","first-page":"15026","DOI":"10.1523\/JNEUROSCI.2024-11.2011","volume":"31","author":"ER Graf","year":"2011","unstructured":"Graf ER, Heerssen HM, Wright CM et al (2011) Stathmin is required for stability of the drosophila neuromuscular junction. J Neurosci 31:15026\u201315034. https:\/\/doi.org\/10.1523\/JNEUROSCI.2024-11.2011","journal-title":"J Neurosci"},{"key":"12070_CR59","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1093\/hmg\/ddz188","volume":"28","author":"E Villal\u00f3n","year":"2019","unstructured":"Villal\u00f3n E, Kline RA, Smith CE et al (2019) AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy. Hum Mol Genet 28:3742\u20133754. https:\/\/doi.org\/10.1093\/hmg\/ddz188","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12070-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12070-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12070-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T08:03:28Z","timestamp":1708934608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12070-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["12070"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12070-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"2 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All patients provided their informed consent for the original genetic analysis that is now retrospectively summarized in this paper, and informed consent was obtained for the publication of patient images. Patient 1 was diagnosed within a standard clinical diagnostics process for which research ethics approval was not required. The RD-Connect GPAP, which was used for analysis of patients 2, 3 and 4, has received ethics approval from the Parc de Salut MAR Clinical Research Ethics Committee on 27 October 2015 under ref. no. 2015\/6456\/I.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval statement"}}]}}